Conclusions
death, non-ischaemic myocardial injury
MYOCARDIAL INFARCTION, SUBSEQUENT MYOCARDIAL INFARCTION, ACUTE CORONARY SYNDROME
In patients with suspected acute coronary syndrome, implementation of a high sensitivity cardiac troponin assay reduced subsequent myocardial infarction or death at five years in those reclassified by the high sensitivity assay. Improvements in outcome were greatest in patients with a diagnosis of non-ischaemic myocardial injury, suggesting cardiac troponin testing may have benefits beyond the identification of myocardial infarction.